activated recombinant human factor VII
F7ICH-1389
Phase 2 small_molecule completed
Quick answer
activated recombinant human factor VII for Acquired Bleeding Disorder is a Phase 2 program (small_molecule) at Novo Nordisk A/S with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Acquired Bleeding Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed